Area of research
Oncology · Molecular Biology
Research interest
Research interests include Medicine, Adverse effect, Immune system, Refractory (planetary science), Internal medicine, and Myocarditis.
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors
Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study
The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects
Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure